Nail-patella syndrome (phalangeal-patellar junction syndrome) is a rare genetic disorder characterized by characteristic abnormalities in the development of nails, joints, and other body systems. The main clinical manifestation of this syndrome is changes in the structure of the nails, including hypoplasia, dysplasia, and underdevelopment, which may be accompanied by deformities of the patella and other joints. The disease is associated with disturbances in the formation and functioning of the mesodermal origin, which leads to complex pathology affecting the musculoskeletal system and dermatological structures. Diagnosis requires a comprehensive approach, including clinical, instrumental, and laboratory studies to confirm genetic abnormalities and exclude other diseases with similar symptoms.
History of the disease and interesting historical facts
Nail-patella syndrome was first described in 1978 by a group of researchers including Carter and Mokar. The description of the condition was based on observations of several related families with similar manifestations, which allowed to identify its hereditary nature. In the following years, additional cases and observations appeared in the medical literature, confirming the connection between mutations of certain genes and the development of this syndrome. An interesting aspect is that despite the rarity of the disease, there are documented cases in various ethnic groups, which emphasizes the peculiarities of its manifestation depending on the population. In addition, the presence of similar clinical manifestations in different patients led to the creation of several international registries to collect data on the disease, which is important for further study of its pathogenesis.
Epidemiology
Currently, nail-patella syndrome is considered a rare disease, with a prevalence of 1 in 100,000 live births. Higher rates have been reported in certain populations with high levels of inbreeding, which may be due to the recessive heredity of this syndrome. Its frequency may also vary depending on the region and ethnicity. Thus, in some communities, cases of this disease are up to 1.5 per 10,000. Studies have shown that the main peak of cases is observed in childhood, but cases of diagnosis in adults are not uncommon, which may be due to a lack of awareness of the disease among health care workers and possible under-examination.
Genetic predisposition to this disease
Nail-patella syndrome is associated with mutations in certain genes, the most significant of which are the KRT17 gene, responsible for the development and structure of keratin, as well as other genes involved in the processes of cell proliferation and differentiation. Mutations in these genes have been found to lead to disruption of the normal formation of nails and patellas. In most cases, the disease is transmitted in an autosomal dominant manner, indicating a high probability of inheritance from one of the parents. There are also rare cases where the syndrome can manifest itself in individuals with no family history of the disease, indicating the possibility of new mutations.
Risk factors for the development of this disease
Risk factors that contribute to the development of nail-patella syndrome include:
- Heredity: presence of sick family members.
- Genetic mutations: changes in genes associated with the formation of nails and joints.
- Environmental factors: Exposure of the fetus to chemicals such as solvents or pesticides during pregnancy.
- Parental age: Increased paternal age may increase the risk of genetic abnormalities in offspring.
- Individual factors: Certain rare conditions such as Chardo or Edwards syndromes may also be underlying factors.
Diagnosis of this disease
The main symptoms of nail-patella syndrome include:
- Deformation and underdevelopment of nails, including their absence on some phalanges.
- Patellar dysplasia, which manifests itself as pain in the knee joints.
- Delayed growth and development in children.
- Possible abnormalities in other systems, for example, in the cardiovascular or genitourinary systems.
Laboratory tests may include genetic testing to identify mutations in specific genes. Radiologic examinations are needed to evaluate the patella, joints, and other bone structures. Other diagnostics may include dermatoscopy to examine the nails. Differential diagnosis is important to rule out conditions such as systemic sclerosis or other genetic syndromes with similar symptoms.
Treatment
Treatment of nail-patella syndrome is complex and may include:
- General treatment: Physical therapy and exercises to improve joint mobility.
- Pharmacological treatment: use of anti-inflammatory and analgesic drugs to reduce pain.
- Surgical treatment: corrective operations on problematic joints and nails in more severe cases.
- Other treatments include using orthotics, such as special insoles or braces, to improve joint function.
List of medications used to treat this disease
The main drugs used for treatment include:
- Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen.
- Steroid anti-inflammatory drugs such as prednisolone in cases of severe inflammation.
- Painkillers, including paracetamol.
- Drugs to improve blood circulation, such as pentoxifylline.
Disease monitoring
Monitoring of patients with nail-patella syndrome includes regular follow-up visits, use of radiological methods to assess the condition of the joints and nails, and monitoring the dynamics of pain and functionality. The prognosis for this disease largely depends on the severity of symptoms and the success of treatment, but many patients can lead relatively normal lives. Complications may include the development of joint contractures and decreased mobility, which requires close monitoring by specialists.
Age-related features of the disease
Nail-patella syndrome may present differently in different age groups. Newborns often have significant nail and joint abnormalities, requiring early intervention. In children under 10 years of age, there may be a significant impact on quality of life due to joint pain, which may affect the development of physical activity and social adaptation. In older patients, symptoms may worsen, increasing the risk of developing comorbidities and worsening quality of life.
Questions and Answers
- What are the main symptoms of nail-patella syndrome? The main symptoms include deformed and underdeveloped nails, patellar dysplasia and possible abnormalities of other systems.
- How is this disease diagnosed? Diagnosis includes clinical examination, genetic testing, radiological examinations and differential diagnosis.
- What is the treatment for nail-patella syndrome? Treatment may include physical therapy, medication, corrective surgery, and the use of orthotics.
- How common is nail-patella syndrome? It is common with a prevalence of approximately 1 in 100,000 live births, although this frequency may vary depending on the population.
- What is the prognosis for patients with this syndrome? The prognosis depends on the severity of symptoms and the effectiveness of treatment; most patients can lead an active lifestyle.
